TUBA1B as a novel prognostic biomarker correlated with immunosuppressive tumor microenvironment and immunotherapy response
Background: Tubulin alpha 1b (TUBA1B) is a key microtubule protein essential for maintaining cellular structure and function. This protein contributes significantly to cytoskeletal formation and is implicated in various diseases. Despite its fundamental roles, TUBA1B’s impact on tumor prognosis and...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-02-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1517887/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832542289507909632 |
|---|---|
| author | Juntao Qi Juntao Qi Mingming Zhou Na Yang Huiyun Ma Min He Gujie Wu Chang Ge Liuyin Jin Lin Cheng Wei Liao Hefei Ren Caiyun Lei |
| author_facet | Juntao Qi Juntao Qi Mingming Zhou Na Yang Huiyun Ma Min He Gujie Wu Chang Ge Liuyin Jin Lin Cheng Wei Liao Hefei Ren Caiyun Lei |
| author_sort | Juntao Qi |
| collection | DOAJ |
| description | Background: Tubulin alpha 1b (TUBA1B) is a key microtubule protein essential for maintaining cellular structure and function. This protein contributes significantly to cytoskeletal formation and is implicated in various diseases. Despite its fundamental roles, TUBA1B’s impact on tumor prognosis and the tumor immune microenvironment across cancer types remains inadequately understood.Methods To elucidate TUBA1B’s role in cancer prognosis and immune response, we conducted a comprehensive analysis, integrating data from established databases such as The Cancer Genome Atlas, Genotype Tissue Expression, Cancer Cell Lineage Encyclopedia, Human Protein Atlas, Kaplan-Meier Plotter, cBioPortal, TIMER, and ImmuCellAI, along with a large-scale clinical study and immunotherapy cohort. We also conducted in vitro functional assays to assess TUBA1B’s functional role in tumor cells, allowing for a detailed examination of its relationship with cancer prognosis and immune modulation.Results: Our findings indicate that TUBA1B expression is dysregulated across multiple cancers, correlating strongly with poor survival outcomes and advanced pathological stages. Functional enrichment analyses further revealed that TUBA1B regulates key cell cycle processes, driving tumor proliferation, migration, and invasion. It also influences immune functions within both the innate and adaptive immune systems, affecting immune-related signaling pathways. These insights underscore TUBA1B’s multifaceted role in cancer progression and immune response.Conclusion: This study highlights TUBA1B’s potential as a human oncogene with substantial roles in tumorigenesis and immune regulation. Elevated TUBA1B levels are associated with an immunosuppressive tumor microenvironment, impacting cancer progression and treatment outcomes. Targeting TUBA1B may offer promising therapeutic avenues for enhancing cancer treatment, offering new perspectives for innovative anti-tumor strategies with high clinical impact. |
| format | Article |
| id | doaj-art-1942d20d56e347c39ba8c8a635929e8d |
| institution | Kabale University |
| issn | 1663-9812 |
| language | English |
| publishDate | 2025-02-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Pharmacology |
| spelling | doaj-art-1942d20d56e347c39ba8c8a635929e8d2025-02-04T06:31:59ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122025-02-011610.3389/fphar.2025.15178871517887TUBA1B as a novel prognostic biomarker correlated with immunosuppressive tumor microenvironment and immunotherapy responseJuntao Qi0Juntao Qi1Mingming Zhou2Na Yang3Huiyun Ma4Min He5Gujie Wu6Chang Ge7Liuyin Jin8Lin Cheng9Wei Liao10Hefei Ren11Caiyun Lei12Rehabilitation Medicine Department, Hunan Aerospace Hospital, Hunan Normal University, Changsha, Hunan, ChinaResearch Center of Clinical Medicine, Shenzhen Hospital of Shanghai University of Traditional Chinese Medicine, Shenzhen, ChinaDepartment of Critical Care Medicine, Chongqing University Affiliated Cancer Hospital, Chongqing, ChinaLaboratory of Oncology and Immunology, School of Basic Medical Sciences, Guangdong Pharmaceutical University, Guangzhou, ChinaResearch Center of Clinical Medicine, Affiliated Hospital of Nantong University, Nantong, ChinaResearch Center of Clinical Medicine, Affiliated Hospital of Nantong University, Nantong, ChinaShanghai Medical College, Fudan University, Shanghai, ChinaSchool of Medicine, Wuhan University, Wuhan, ChinaSchool of Medicine, Wuhan University, Wuhan, ChinaShanghai Medical College, Fudan University, Shanghai, ChinaDepartment of Otolaryngology and Head and Neck Surgery, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, Guangdong, ChinaDepartment of Laboratory Medicine, Changzheng Hospital, Naval Medical University, Shanghai, ChinaRehabilitation Medicine Department, Hunan Aerospace Hospital, Hunan Normal University, Changsha, Hunan, ChinaBackground: Tubulin alpha 1b (TUBA1B) is a key microtubule protein essential for maintaining cellular structure and function. This protein contributes significantly to cytoskeletal formation and is implicated in various diseases. Despite its fundamental roles, TUBA1B’s impact on tumor prognosis and the tumor immune microenvironment across cancer types remains inadequately understood.Methods To elucidate TUBA1B’s role in cancer prognosis and immune response, we conducted a comprehensive analysis, integrating data from established databases such as The Cancer Genome Atlas, Genotype Tissue Expression, Cancer Cell Lineage Encyclopedia, Human Protein Atlas, Kaplan-Meier Plotter, cBioPortal, TIMER, and ImmuCellAI, along with a large-scale clinical study and immunotherapy cohort. We also conducted in vitro functional assays to assess TUBA1B’s functional role in tumor cells, allowing for a detailed examination of its relationship with cancer prognosis and immune modulation.Results: Our findings indicate that TUBA1B expression is dysregulated across multiple cancers, correlating strongly with poor survival outcomes and advanced pathological stages. Functional enrichment analyses further revealed that TUBA1B regulates key cell cycle processes, driving tumor proliferation, migration, and invasion. It also influences immune functions within both the innate and adaptive immune systems, affecting immune-related signaling pathways. These insights underscore TUBA1B’s multifaceted role in cancer progression and immune response.Conclusion: This study highlights TUBA1B’s potential as a human oncogene with substantial roles in tumorigenesis and immune regulation. Elevated TUBA1B levels are associated with an immunosuppressive tumor microenvironment, impacting cancer progression and treatment outcomes. Targeting TUBA1B may offer promising therapeutic avenues for enhancing cancer treatment, offering new perspectives for innovative anti-tumor strategies with high clinical impact.https://www.frontiersin.org/articles/10.3389/fphar.2025.1517887/fullTUBA1Bprognosisbiomarkertumor microenvironmentanti-tumor strategies |
| spellingShingle | Juntao Qi Juntao Qi Mingming Zhou Na Yang Huiyun Ma Min He Gujie Wu Chang Ge Liuyin Jin Lin Cheng Wei Liao Hefei Ren Caiyun Lei TUBA1B as a novel prognostic biomarker correlated with immunosuppressive tumor microenvironment and immunotherapy response Frontiers in Pharmacology TUBA1B prognosis biomarker tumor microenvironment anti-tumor strategies |
| title | TUBA1B as a novel prognostic biomarker correlated with immunosuppressive tumor microenvironment and immunotherapy response |
| title_full | TUBA1B as a novel prognostic biomarker correlated with immunosuppressive tumor microenvironment and immunotherapy response |
| title_fullStr | TUBA1B as a novel prognostic biomarker correlated with immunosuppressive tumor microenvironment and immunotherapy response |
| title_full_unstemmed | TUBA1B as a novel prognostic biomarker correlated with immunosuppressive tumor microenvironment and immunotherapy response |
| title_short | TUBA1B as a novel prognostic biomarker correlated with immunosuppressive tumor microenvironment and immunotherapy response |
| title_sort | tuba1b as a novel prognostic biomarker correlated with immunosuppressive tumor microenvironment and immunotherapy response |
| topic | TUBA1B prognosis biomarker tumor microenvironment anti-tumor strategies |
| url | https://www.frontiersin.org/articles/10.3389/fphar.2025.1517887/full |
| work_keys_str_mv | AT juntaoqi tuba1basanovelprognosticbiomarkercorrelatedwithimmunosuppressivetumormicroenvironmentandimmunotherapyresponse AT juntaoqi tuba1basanovelprognosticbiomarkercorrelatedwithimmunosuppressivetumormicroenvironmentandimmunotherapyresponse AT mingmingzhou tuba1basanovelprognosticbiomarkercorrelatedwithimmunosuppressivetumormicroenvironmentandimmunotherapyresponse AT nayang tuba1basanovelprognosticbiomarkercorrelatedwithimmunosuppressivetumormicroenvironmentandimmunotherapyresponse AT huiyunma tuba1basanovelprognosticbiomarkercorrelatedwithimmunosuppressivetumormicroenvironmentandimmunotherapyresponse AT minhe tuba1basanovelprognosticbiomarkercorrelatedwithimmunosuppressivetumormicroenvironmentandimmunotherapyresponse AT gujiewu tuba1basanovelprognosticbiomarkercorrelatedwithimmunosuppressivetumormicroenvironmentandimmunotherapyresponse AT changge tuba1basanovelprognosticbiomarkercorrelatedwithimmunosuppressivetumormicroenvironmentandimmunotherapyresponse AT liuyinjin tuba1basanovelprognosticbiomarkercorrelatedwithimmunosuppressivetumormicroenvironmentandimmunotherapyresponse AT lincheng tuba1basanovelprognosticbiomarkercorrelatedwithimmunosuppressivetumormicroenvironmentandimmunotherapyresponse AT weiliao tuba1basanovelprognosticbiomarkercorrelatedwithimmunosuppressivetumormicroenvironmentandimmunotherapyresponse AT hefeiren tuba1basanovelprognosticbiomarkercorrelatedwithimmunosuppressivetumormicroenvironmentandimmunotherapyresponse AT caiyunlei tuba1basanovelprognosticbiomarkercorrelatedwithimmunosuppressivetumormicroenvironmentandimmunotherapyresponse |